Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
about
The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosisIncidence and risk factors for extensively drug-resistant tuberculosis in Delhi regionDetection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon SequencingCurrent developments and future perspectives for TB diagnostics.Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosisComparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South AfricaSecond-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assayRole of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settingsLaboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesCorrelating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assayRifapentine-proliposomes for inhalation: in vitro and in vivo toxicity.Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutationsGenotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Evaluating Shared Laboratory Services: Detecting Mycobacterium Tuberculosis Complex and Drug Resistance Using Molecular and Culture-Based Methods.Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.Drug resistance patterns in 111 cases of drug-resistant tuberculosis spine.Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern CapePrevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens.De-novo XDR Tuberculosis Spine in a 3-year-old Girl.Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs.Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.
P2860
Q28397729-BF99B4ED-3192-4C64-96F0-5ABCB439A4F4Q28485946-7F4AFB63-53E9-4521-9A8C-A3DA2D38A9F6Q28547220-74CCCD89-1AED-4A62-9DC9-6D7123DBDB3AQ30410962-7880040F-AC24-4405-9D91-7079DE07C595Q30425212-608882AF-5B49-43BC-A81C-6CB8760E6487Q34046372-21F0BD34-9DCF-475D-9911-93B5450D17B8Q34520274-5D916A9C-D7C2-46E7-BFAD-AE09EF20BA82Q34604407-983933F7-D410-4DFC-948F-EC3DDF330E5FQ34741471-B68FF9E4-6AC5-4DB2-8818-FDA650DD5412Q35066020-F5E004CE-A3B7-486E-B36A-A1BD4CF385BFQ35181330-1F75B017-05E1-4D12-82F8-E5864423C28AQ35549569-EAB22B4B-2AB7-4E02-B8C8-340F8854B6BFQ35599028-89751DE8-3BEF-4B14-B77D-0AE7DB353D31Q36165509-62C8CF0B-AC82-452E-9121-7A6AFD136AC4Q36290565-7E21B4F6-F3E7-433F-AC1D-66D4C910EE31Q36472787-3707488E-F3DB-4D37-8D98-06EA3563F745Q36773017-2E27999B-BB40-4343-BEE0-B1719C34F2D3Q36951876-F47D4D23-076F-46B0-9D07-C36F186ECFEEQ37023127-8865D545-314D-479F-BB0D-00578129493CQ37036485-62485697-99EA-4A39-8214-4EC789276F6AQ37546274-4AC7C516-ECC3-49F7-8159-56FC54ECFF0DQ37695807-462390D9-1907-4941-89E0-3CD1F0846999Q38059860-199071CE-381D-488C-9FDB-266F7DEA4381Q38320793-229C4975-3249-4114-8920-41EE313B6D52Q38839490-714C22D9-3CBE-4D38-9C55-833DF8CAF067Q41826690-E2E02C86-52C9-4951-B8A4-B73B82D30186
P2860
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@en
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@nl
type
label
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@en
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@nl
prefLabel
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@en
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@nl
P2093
P2860
P356
P1476
Multicenter evaluation of Bact ...... acterium tuberculosis complex.
@en
P2093
Donald Bonato
Edward Desmond
S-Y Grace Lin
Salman Siddiqi
Wendy Gross
P2860
P304
P356
10.1128/JCM.00803-09
P407
P577
2009-09-09T00:00:00Z